Save your place

Sign in to WhoBought

Please try again later.

Ken Griffin's Forte Biosciences, Inc. (FBRX) position

Not anymore: Ken Griffin fully exited FBRX in Q3 2024. The position peaked at $99M in Q1 2021.
View full portfolio →
Value at exit
$109K
Shares at exit
8K
Est. average buy price (i)
$16.39
Quarter-end price
$13.43

Estimated trade prices

Average price in quarters with purchases
$128.75
Average prices in quarters with sales
  • Q2 2024: $16.15 (20K shares sold)
  • Q1 2023: $25.15 (5K shares sold)
  • Q2 2022: $31.76 (150K shares sold)
  • Q1 2022: $37.84 (17K shares sold)
  • Q2 2021: $901.12 (105K shares sold)

FBRX price vs Griffin's position

1Y 3Y 5Y MAX
Dates
$4$500$1,00020222023202420252026Added 42K shares (430.4%) · Q3 2021. Average closing price $553.99 · Price range $74.00–$916.7542KsharespurchasedAdded 196K shares (376.0%) · Q4 2021. Average closing price $67.26 · Price range $50.50–$84.00196KsharespurchasedSold 17K shares (6.8%) · Q1 2022. Average closing price $37.84 · Price range $30.25–$56.0017KsharessoldSold 150K shares (64.9%) · Q2 2022. Average closing price $31.76 · Price range $26.88–$38.75150KsharessoldNew position of 5K shares · Q4 2022. Average closing price $25.63 · Price range $24.16–$28.005KsharespurchasedSold 5K shares (98.5%) · Q1 2023. Average closing price $25.15 · Price range $24.38–$26.505KsharessoldAdded 22K shares (over 1,000%) · Q2 2023. Average closing price $25.97 · Price range $24.57–$27.7522KsharespurchasedNew position of 9K shares · Q4 2023. Average closing price $13.97 · Price range $9.50–$20.549KsharespurchasedAdded 20K shares (227.5%) · Q1 2024. Average closing price $17.45 · Price range $12.09–$21.2520KsharespurchasedSold 20K shares (71.3%) · Q2 2024. Average closing price $16.15 · Price range $11.50–$19.5020Ksharessold← Earlier —1 sell
Average closing price · filing quarter
$16.15
Price range · filing quarter
$11.50 – $19.50
Sign in to see who bought

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q3 2024 Exited −8K −$83K −100.0% 0 Nov 14, 2024
Q2 2024 Reduced −20K −$325K −71.3% 8K Aug 14, 2024
Q1 2024 Added +20K +$342K +227.5% 28K May 15, 2024
Q4 2023 New +9K +$120K – 9K Feb 14, 2024
Q2 2023 Added +22K +$583K +33,489.6% 23K Aug 14, 2023
Q1 2023 Reduced −5K −$113K −98.5% 67 May 15, 2023
Q4 2022 New +5K +$117K – 5K Feb 14, 2023
Q2 2022 Reduced −150K −$4.8M −64.9% 81K Aug 15, 2022
Q1 2022 Reduced −17K −$642K −6.8% 232K May 16, 2022
Q4 2021 Added +196K +$13M +376.0% 249K Feb 14, 2022
Q3 2021 Added +42K +$23M +430.4% 52K Nov 15, 2021
Q2 2021 Reduced −105K −$95M −91.4% 10K Aug 16, 2021
Q1 2021 First covered – – – 115K May 21, 2021
Data through Q3 2024 · filed Nov 14, 2024
13 grouped rows from 13 quarters

More Griffin positions

NVIDIA Corporation(NVDA)
$3.2B
2.3% of portfolio

Amazon.com, Inc.(AMZN)
$1.7B
1.2% of portfolio

Micron Technology, Inc.(MU)
$1.6B
1.1% of portfolio

Taiwan Semiconductor Manufacturing Company Limited(TSM)
$1.4B
1.0% of portfolio

Apple Inc.(AAPL)
$1.3B
0.9% of portfolio

Meta Platforms, Inc.(META)
$1.0B
0.7% of portfolio

Common questions

Does Ken Griffin own FBRX?

Not currently. Ken Griffin fully exited FBRX in Q3 2024, and the complete history is above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Ken Griffin buy FBRX?

Ken Griffin held FBRX since at least Q1 2021, when this filing coverage begins; the opening snapshot is not a disclosed purchase. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Ken Griffin sell FBRX?

Yes. Ken Griffin reduced and then fully exited FBRX by Q3 2024; the reductions are in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of FBRX does Ken Griffin own?

None as of the latest filing: Ken Griffin has exited FBRX. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Ken Griffin pay for FBRX?

Ken Griffin's estimated average buy price for FBRX is $16.39, from quarter-average prices weighted by the shares added each quarter. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.